Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study

Indian Journal of Nephrology

Volumn 20, Issue 1, 2010, Pages 15-20

  Jalal, S ^a   Sofi, F A ^a   Abass, S M ^a   Alai, M S ^a   Bhat, M A ^a   Rather, H A ^a   Lone, N A ^a   Siddiqi, M A ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium channel blockers; Hypertension; Microalbuminuria

Indexed keywords

ALBUMIN; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; LISINOPRIL;

ADULT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; MORBIDITY; MORTALITY; PROTEIN SECRETION; SCREENING; SYSTOLIC BLOOD PRESSURE;

EID: 77953434342     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.62090     Document Type: Article

References (30)

1. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of mocroalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992;61:94-97
2. Jalal S, Sofi FA, Alai MS, Siddiqqi MA, Bhat MA, Khan KA, et al. Prevalence of microalbuminuria in essential hypertension: A study of patients with mild to moderate hypertension. Indian J Nephrol 2001;11:6-11.
3. Parving HH, Mogensen CE, Evrin PE. Increased urinary albumin excretion in benign essential hypertension. Lancet 1974;1:231-237
4. Losito A, Fortunati F, Zampi I, Del Favero A. Impaired functional reserve and albuminuria in essential hypertension. Br Med J 1988;1:1562-1564
5. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, et al. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild hypertension. Am J Hypertens 1989;2:259-261 (Pubitemid 19087206)
6. Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertension: Effects of several antihypertensive drugs. Am J Med 1992;93:525-528
7. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Lancet 1988;2:530-533
8. Marre M, Leblane H, Suarez L, Guyenne TT, Menard J, Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. BMJ 1987;294:1448-1452 (Pubitemid 17079620)
9. Reams GP, Bauer JH. Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction. Arch Intern Med 1986;146:2145-2148
10. Bakris GL. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 1990;113:987-988
11. Mickish O, Schmid M, Mann JF, Helder T, Bergen F, Rauterberg EW, et al. Calcium antagonisteu bei chronischer Niereu Suffizions. Dtsch Med WO Chenschr 1988;113:1546-1548
12. Ferdes L, Daccordi HA, Martello M, Marisa P, Inserra F. ACE inhibitors versus calcium channel antagonists in the treatment of diabetic hypertensive patients. Hypertension 1991;17:453.
13. Baba T, Murabayashi S, Takebe K. Comparison of the renal effects of ACE inhibitor and calcium antagonist in hypertensive type 2 (non-insulin dependent) diabetic patients will microalbuminuria in a randomized, controlled trial. Diabetalgia 1989;32:40-44 (Pubitemid 19061740)
14. Stornello M, Valvo EV, Scapellato L. Hemodynamic, renal and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captropril in hypertensive type II diabetic patients with nephropathy. J Cardiovasc Pharmacol 1989;14:851-855 (Pubitemid 20008843)
15. Bauer JH, Reems GP. Do calcium antagonists protect the human hypertensive kidney? Am J Hypertens 1989;2:s173-8.
16. Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertensive: Effect of an angiotensin converting enzyme inhibitor and of a calcium channel blocker. Am J Hypertens 1991;4:291-296
17. Dennis VW, Robinson RR. Proteinuria. In: Seldin DW, Giebisch, editors. The kidney: Physiology and pathophysiology New York: Raven Press; 1985.
18. Ljungman S, Aurell M, Hartford M, Wikstrand J, Wilhelmsen L, Berglund G. Blood pressure and renal functions. Acta Med Scand 1980;208:17-25.
19. Mayers BD, Deen WM, Brenner BM. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in rat. Circ Res 1975;37:101-110
20. Deen WM, Satvat B. Determinants of the glomerular filtration of proteins. Am J Physiol 1981;241:FI62-70. (Pubitemid 11044065)
21. Raineri G, Andriani A, Lamontaneva G, DeCesaris R. Effects of lisinopril and amlodipine on microalbuminuria and renal functions in patients with hypertension. Clin Pharmacol Ther 1994;56:323-3 0. (Pubitemid 24323924)
22. Alli C, Lombardo M, Zanni D, Agrati AM, Cassani M, Granata S. Albuminuria and transferrinuria in essential hypertension: Effects of antihypertensive therapy. Am J Hypertens 1996;9:1068-1076 (Pubitemid 26383489)
23. White WB, Duprez D, St Hillaire R, Krause S, Roniker B, Kuse-Hamilton J, et al. Effects of selective aldosterone blocker eplerinone versus the calcium channel antagonist, amlodipine in systolic hypertension. Hypertension 2003;41:1021-1026 (Pubitemid 36548598)
24. De Cesaris R, Ranieri G, Filitti V, Andriani A, Bonfantino MV. Effects of atenolol and enalapril on kidney function in hypertensive diabetic patients. J Cardiovasc Pharmacol 1993;22:208-214 (Pubitemid 23225145)
25. Heeg lE, De Long PE, Van Der Hem GK, de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989;36:272-279 (Pubitemid 19202486)
26. Murelli E, Loon N, Meyer T, Peters W, Myers BD. Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990;39:2-8.
27. Dzau VI. Angiotensin converting enzyme as a multimechanistic factor in CAD. J Myocard Ischemia 1995;7:6-14.
28. Cody RJ. The integrated effects of Angiotensin II. Am J Cardiol 1997;79:9-11.
29. Zanetti-Elshater F, Pingitore R, Beretta-Piecoli C, Riesen W, Heinen G. Calcium antagonists for treatment of diabetes-associated hypertension: Metabolic and renal effects of amlodipine. Am J Hypertens 1994;7:36-45. (Pubitemid 24033217)
30. Kleinert S. HOPE for cardiovascular disease prevention with ACE inhibitor, ramipril: Heart outcomes prevention evaluation. Lancet 1999;354:841.